Medical Associations Compromised Scientific Integrity on Youth Gender Care Through Political Advocacy
Source: https://www.nytimes.com/by/jesse-singal. "Opinion | On Youth Gender Care, Medical Associations Hurt Their Credibility - The New York Times." February 24, 2026. www.nytimes.com
The Gist
The author argues that major American medical groups hurt their reputation by claiming there was strong scientific support for treating transgender youth with hormones and surgery, when the evidence was actually weak. Recent policy changes and European research reviews show these groups were more focused on political advocacy than honest science.
Conclusion
Major American medical associations have damaged their credibility by prioritizing political advocacy over scientific rigor when endorsing youth gender medicine, creating false consensus claims that contradict emerging evidence and transparent European reviews.
Premises
- Medical associations claimed overwhelming scientific consensus supporting youth gender medicine despite weak evidence, using phrases like 'the science is settled' and 'medically necessary'
- Recent developments show cracks in this supposed consensus, with the American Society of Plastic Surgeons and American Medical Association now questioning youth gender surgeries
- The 2024 Cass review found 'remarkably weak' evidence for youth gender medicine and revealed that professional guidelines relied heavily on other organizations' guidelines rather than independent evidence evaluation
- European countries that conducted systematic evidence reviews (Finland, Sweden, Britain) found deep uncertainty about the evidence base and began restricting youth gender medicine
- American professional organizations wrote politically motivated documents opposing state restrictions, routinely exaggerating the evidence base for these treatments
- The American Psychological Association published contradictory statements in 2024 and 2025, with the later document essentially calling the earlier one 'misinformation'
- These organizations lack transparency about their policy development processes, making it impossible to assess whether scientific rigor or political considerations drove their positions
Assumptions
- Scientific organizations should prioritize evidence-based analysis over political advocacy
- Transparency in policy development processes is essential for maintaining scientific credibility
- European systematic evidence reviews are more reliable than American professional organization statements
- The recent policy reversals indicate previous positions were politically rather than scientifically motivated
- Public trust in medical institutions depends on their commitment to scientific integrity over advocacy